Drugs / CDD-2105
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06319729 | Mar → Aug 2024 | irritable bowel syndrome | Hong Kong Baptist University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CDD-2105 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06319729 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “a Chinese herbal medicine formula” NCT06319729 ↗ |